Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Northern Ireland maps next 20 years' cancer care:

This article was originally published in Clinica

Executive Summary

New cancer screening programmes and services that incorporate the latest technological developments are among the priorities of Northern Ireland's new regional cancer services framework group. The group, will seek to identify key modernisation issues, "in the light of emerging research, new technologies, policy changes and best practice elsewhere". A report to be produced by the end of 2004 will set out a concrete programme of action to 2008, recommendations for service development to 2015 and a "strategic direction" to 2024.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057697

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel